Lipodystrophy in juvenile-onset dermatomyositis - The Lancet Rheumatology thelancet.com/journals/lanrh…

Emulated target trial of abatacept vs rituximab in RA-ILD found abatacept was assoc with lower risk of all-cause mortality in overall & subgroup & sensitivity analyses. Potential residual confounding by indication warrants caution in interpretation A&R doi.org/10.1002/art.43…

Our study shows supporting evidence for psychometric properties of SF-36 in health related quality of life assessment in patients with #myositis. It was great working with Almurtada Razok on this paper! Dr. Kaleb Michaud

In this cohort of patients who underwent >1 muscle biopsy, repeat biopsy achieved a specific diagnosis in 43% of cases and impacted clinical decision-making. The highest yield was when IBM was suspected, or when B1 showed non-specific myopathy. onlinelibrary.wiley.com/doi/10.1002/mu…

This study evaluated several algorithms for identifying dermatomyositis cases across a range of different databases. Performance varied widely. Selected good performers for incidence & prevalence had sensitivity of 42% & 49%, and PPV 83% & 84%, resp. AC&R doi.org/10.1002/acr.25…

Our recent study Seminars in Arthritis and Rheumatism demonstrated good measurement properties for sit to stand and timed up and go tests when self-performed by patients with #myositis at home, while six min walk distance was significantly lower at home compared to office sciencedirect.com/science/articl…

This month marks my 1-year at Rush Rheumatology and I am so proud of my research team at Rush Myositis Program - you will meet most of these bright and talented people presenting their #myositis research at #ACR25 in Chicago ✨

📣Two complementary manuscripts this month: one provides an in-dept overview of #myositis classification criteria to date & rationale for revision of 2017 criterion, while the other one reports the results of the first step of revision project (MyoROC) 🎸 sciencedirect.com/science/articl…

It was such a pleasure to talk about #myositis at Virginia Society of Rheumatology and catch up with friends!

Today is World #Myositis Day! 🤍

📢We, Rush Myositis, are conducting a survey study to understand the pain experienced by patients living with #myositis. The survey is anonymous, and should not take >15 mins to complete. Thank you! Here is the link:🔗redcap.link/2iq2pih3 The Myositis Association Myositis Support and Understanding (MSU)

Fantastic #myositis lecture by Jens Schmidt #ACR25 Review Course, moderated by Julie J. Paik. So great to catch up with colleagues in Chicago! ⭐️

Knowledge bowl starting now! #ACR25 Great teams, excellent competition ⭐️

Proud of our second year rheumatology fellow, Haley Zimmerman, and chief resident, Almurtada Razok, presenting their #myositis research #ACR25

Nothing like science and friends all in one place #ACR25

Myma Albayda, MD, RhMSUS introduced the Hopkins Myositis Grading Scale: a new 4-point #ultrasound scale for #myositis showing stronger validity & reliability than Heckmatt scale. κ up to 0.85, rho 0.62. Better precision, even for less experienced raters. #ACR25 #USSONAR #Ultrasound #meded

Knowledge bowl final round is starting now #ACR25 w Mike Putman, Joanna Marco and superstar finalists ⭐️

✨💫Excellent #myositis research presentations by MS-II, Sung-Ki Lee Rush University System for Health and IM resident Anuya Natu #ACR25 Rush Myositis #FORWARD

It was a pleasure to co-moderate the Perimyocarditis in Autoimmune Diseases session with Eugene Krustev #ACR25 Julie J. Paik